Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suiviritux: Long-term Rituximab Evaluation in Pemphigus
NCT01299857Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Jun 2011
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in pemphigus, sponsored by Rouen University Hospital. Started Jun 2011; status: completed.
02
Drugs
rituximab
03
Conditions
pemphigus
Beyond the preview
Go deeper on NCT01299857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299857.